Skin Care Drug Co. Timber Gets OK For Ch. 11 Sale To Lender

By Vince Sullivan · January 22, 2024, 6:22 PM EST

A Delaware bankruptcy judge on Monday approved dermatology drug developer Timber Pharmaceuticals' plan for a Chapter 11 sale of its assets, with the debtor telling the court it intended to close...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Trex Wind-down, Inc.

Case Number

Court

Delaware

Nature of Suit

Date Filed

November 17, 2023

Recent Articles By Vince

May 17, 2024
Healthcare Co. Sues Steward In Ch. 11 Over Military Contract
March 12, 2024
Breast Implant Co.'s $90M DIP OK'd With Creditor Protections
March 04, 2024
Hospital Operator Pushes For Ch. 11 Plan Confirmation
February 06, 2024
Cano Health DIP Gets Initial OK Without $23M Lender Fees
January 10, 2024
US Trustee Calls SmileDirect Ch. 11 Deal An Improper Plan
December 06, 2023
GenesisCare Gets OK For $20M DIP Funding Hike
December 01, 2023
Alecto Health Can Continue With Subchapter V Designation
November 29, 2023
Alecto Health Co. Says Threshold Met For Subchapter V Status
November 21, 2023
Dermatology Drug Developer Can Tap $3M Of Ch. 11 Loan
November 20, 2023
Pharma Co. RevitaLid Approved For Ch. 11 Equity Swap Plan